This analysis provides a quarterly overview of the strategic adjustments made to Tweedy Browne's 13F portfolio, offering insights into their investment decisions and market positioning.
Unpacking Tweedy Browne's Latest Investment Moves
Tweedy Browne's Portfolio Overview in Q4 2025: A Deep Dive into Key Holdings
In the fourth quarter of 2025, Tweedy Browne's 13F portfolio witnessed a significant increase, reaching an impressive total value of $1.24 billion. A notable change in this period was Ionis Pharmaceuticals, which emerged as the largest holding, now constituting a substantial 15.74% of the entire portfolio. This shift indicates a strong conviction in the pharmaceutical sector and particularly in Ionis's future prospects.
Major Portfolio Adjustments: Increases, Reductions, and New Entrants
During this quarter, Tweedy Browne strategically increased its stake in CNH Industrial, signaling a positive outlook on the company's performance and market position. Conversely, the firm substantially reduced its holdings in both Ionis (despite it becoming the largest position, indicating a rebalancing after prior heavy investment) and Alphabet, suggesting a cautious approach or profit-taking in these high-profile companies. Furthermore, Tweedy Browne initiated a new position by investing in UniFirst Corp., introducing a fresh asset to its diverse portfolio. Concurrently, the firm nearly exited its investment in FMC Corporation, following aggressive divestment activities in previous quarters, which reflects a strategic shift away from this sector.
Concentrated Conviction: The Dominance of Top Holdings
The firm's investment philosophy is clearly demonstrated by the concentrated nature of its top five holdings. Ionis Pharmaceuticals (IONS), CNH Industrial (CNH), Berkshire Hathaway Class B (BRK.B), Coca-Cola Femsa (KOF), and Alphabet (GOOGL) collectively account for approximately 58% of the total portfolio. This high concentration underscores Tweedy Browne's high-conviction approach, where significant capital is allocated to a select group of companies that the firm believes offer the most promising long-term value and growth potential.
